Desipramine versus phenelzine in recurrent unipolar depression: Clinical characteristics and treatment response

Journal of Clinical Psychopharmacology

Volumn 17, Issue 2, 1997, Pages 78-83

  Swann, Alan C ^a   Bowden, Charles L ^b   Rush, A John ^c   Rhoades, Howard ^a   Rose, Robert ^d   Kobes, Rodger ^e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d MacArthur Foundation   (United States)

^e Blue Cross and Blue Shield of Texas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESIPRAMINE; PHENELZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR DEPRESSION; MALE; OUTPATIENT; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DESIPRAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PHENELZINE; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; STATISTICS, NONPARAMETRIC;

EID: 0030888147     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199704000-00002     Document Type: Article

References (20)

1. Baldessarini RJ. Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatry 1989;50:117-26.
2. Thase ME, Trivedi MH, Rush AJ Jr. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology 1995;12: 185-219.
3. Liebowitz M, Quitkin F, Stewart J, McGrath P, Harrison W, Markowitz J, Rabkin J, Tricamo E, Goetz D, Klein D. Antidepressant specificity in atypical depression. Arch Gen Psychiatry 1988; 45:129-37.
4. Quitkin F, Stewart J, McGrath P, Liebowitz M, Harrison W, Tricamo E, Klein D, Rabkin J, Markowitz J, Wager S. Phenelzine versus imipramine in the treatment of probable atypical depression: defining symptom boundaries of selective MAOI responders. Am J Psychiatry 1988;145:306-11.
5. Vallejo J, Gasto C, Catalan R, Salamero M. Double-blind study of imipramine versus phenelzine in melancholias and dysthymic disorders. Br J Psychiatry 1987;151:639-42.
6. Paykel ES, Rowan PR, Rao BM, Bhat A. Atypical depression: nosology and response to antidepressants. In: Clayton P, Barrett J, ed. Treatment of depression: old controversies and new approaches. New York: Raven Press, 1983:237-52.
7. Ravaris C, Robinson D, Ives J, Nies A, Bartlett D. Phenelzine and amitriptyline in the treatment of depression: a comparison of present and past studies. Arch Gen Psychiatry 1980;37:1075-80.
8. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
9. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C. The inventory for depressive symptomatology (IDS): preliminary findings. Psychiatry Res 1986;18:65-87.
10. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
11. Overall JE, Hollister LE, Johnson M, Pennington V. Nosology of depression and differential response to drugs. JAMA 1966;195: 946-8.
12. Croughan J, Secunda S, Katz MM, Robins E, Mendels J, Swann AC, Harris-Larkin B. Sociodemographic and prior clinical course characteristics associated with treatment response in depressed patients. J Psychiatr Res 1988;22:227-37.
13. Himmelhoch JM, Thase ME, Mallinger AG, Houck P. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991;148:910-6.
14. Angst J, Stabl M. Efficacy of moclobemide in different patient groups: a meta-analysis of studies. Psychopharmacology (Berl) 1992;106:S109-S113.
15. Joyce PR, Paykel ES. Predictors of drug response in depression. Arch Gen Psychiatry 1989;46:89-99.
16. Simpson GM, Pi EH, Gross L, Baron D, November M. Plasma levels and therapeutic response with trimipramine treatment in endogenous depression. J Clin Psychiatry 1988;49:113-6.
17. Coryell W, Turner R. Outcome with desipramine therapy in subtypes of nonpsychotic major depression. J Affect Disord 1985;9: 149-54.
18. Paykel ES, Hollyman JA, Freeling P, Sedgwick P. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J Affect Disord 1988;14: 83-95.
19. Swann AC, Secunda SK, Stokes PE, Croughan JC, Davis JM, Koslow SH, Maas JW. Stress, depression, and mania: relationship between perceived role of stressful events and clinical and biochemical characteristics. Acta Psychiatr Scand 1990;81:389-97.
20. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992;149: 999-1010.